Expression of calcyclin in human melanoma cell lines correlates with metastatic behavior in nude mice. 1992

M A Weterman, and G M Stoopen, and G N van Muijen, and J Kuznicki, and D J Ruiter, and H P Bloemers
Department of Biochemistry, University of Nijmegen, The Netherlands.

Since our aim was to isolate and identify new progression markers of human cutaneous melanoma, we applied the differential hybridization technique, in which we compared the gene expression in two subsequent stages of this progression. Tumors in nude mice arising after transplantation and serial passage in vivo of either the horizontally and early vertically growing part or the advanced vertically growing part of a primary melanoma of the same patient were used for this assay. This resulted in the isolation of a number of complementary DNA clones that were differentially expressed. Based on the marked difference in expression, one of them, designated pMW1, was chosen for further characterization and appeared to be coding for calcyclin, a cell cycle-regulated protein, belonging to a family of small calcium-binding proteins. Calcyclin expression was elevated in high-metastatic human melanoma cell lines in nude mice compared to low-metastatic ones. Immunoprecipitation of calcyclin showed that the differential expression at the RNA level is also reflected at the protein level. These findings show that expression of calcyclin is related to metastasis of human melanoma cell lines in nude mice and emphasize the role of this family of calcium-binding proteins in neoplastic progression as was reported for the mouse homologue of calcyclin and other members of the same family.

UI MeSH Term Description Entries
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009418 S100 Proteins A family of highly acidic calcium-binding proteins found in large concentration in the brain and believed to be glial in origin. They are also found in other organs in the body. They have in common the EF-hand motif (EF HAND MOTIFS) found on a number of calcium binding proteins. The name of this family derives from the property of being soluble in a 100% saturated ammonium sulfate solution. Antigen S 100,Nerve Tissue Protein S 100,S100 Protein,S-100 Protein,S100 Protein Family,Protein, S100,S 100 Protein
D002135 Calcium-Binding Proteins Proteins to which calcium ions are bound. They can act as transport proteins, regulator proteins, or activator proteins. They typically contain EF HAND MOTIFS. Calcium Binding Protein,Calcium-Binding Protein,Calcium Binding Proteins,Binding Protein, Calcium,Binding Proteins, Calcium,Protein, Calcium Binding,Protein, Calcium-Binding
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005784 Gene Amplification A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication. Amplification, Gene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000075383 S100 Calcium Binding Protein A6 An S100 calcium binding protein that contains two EF HAND MOTIFS and plays a role as a calcium sensor and modulator for many cellular processes such as CELL CYCLE progression; CELL MOTILITY and reorganization of the ACTIN CYTOSKELETON. Its expression is induced by growth factors and it is overexpressed in patients with ACUTE MYELOID LEUKEMIA. Calcyclin,S100-A6 Protein,S100A6 Protein,S100 A6 Protein

Related Publications

M A Weterman, and G M Stoopen, and G N van Muijen, and J Kuznicki, and D J Ruiter, and H P Bloemers
June 1994, Cancer research,
M A Weterman, and G M Stoopen, and G N van Muijen, and J Kuznicki, and D J Ruiter, and H P Bloemers
October 1991, The Journal of cell biology,
M A Weterman, and G M Stoopen, and G N van Muijen, and J Kuznicki, and D J Ruiter, and H P Bloemers
January 1995, International journal of cancer,
M A Weterman, and G M Stoopen, and G N van Muijen, and J Kuznicki, and D J Ruiter, and H P Bloemers
May 1979, Journal of the National Cancer Institute,
M A Weterman, and G M Stoopen, and G N van Muijen, and J Kuznicki, and D J Ruiter, and H P Bloemers
August 1984, Cancer research,
M A Weterman, and G M Stoopen, and G N van Muijen, and J Kuznicki, and D J Ruiter, and H P Bloemers
January 2003, International journal of gastrointestinal cancer,
M A Weterman, and G M Stoopen, and G N van Muijen, and J Kuznicki, and D J Ruiter, and H P Bloemers
July 1982, British journal of cancer,
M A Weterman, and G M Stoopen, and G N van Muijen, and J Kuznicki, and D J Ruiter, and H P Bloemers
October 1993, The Journal of dermatology,
M A Weterman, and G M Stoopen, and G N van Muijen, and J Kuznicki, and D J Ruiter, and H P Bloemers
December 1992, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie,
M A Weterman, and G M Stoopen, and G N van Muijen, and J Kuznicki, and D J Ruiter, and H P Bloemers
January 1992, Cancer immunology, immunotherapy : CII,
Copied contents to your clipboard!